Optometrist, Low Vision Rehabilitation · Little Neck, NY
NPI
1104821842
Since 2005
Specialty
Optometrist, Low Vision Rehabilitation
Code 152WL0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
5221 Little Neck Pkwy
Little Neck, NY, 11362
Phone (718) 281-1015
Groups this clinician bills Medicare through
Medicare paid, 2024
$518K
11,623 services
Medicare patients, 2024
1,366
Average age 79
Drug cost, 2024
$564K
2,532 prescriptions
Company payments, 2025
$60.13
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Givner was code 83861 (clinical chemistry), 3,273 times for 1,282 patients. In total Steven Givner billed 11,623 services in 19 codes, and Medicare paid $518K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83861 Clinical Chemistry | Office | 3,273 | 1,282 | $22.03 | $72K |
| 92014 Ophthalmological E&M | Office | 1,332 | 1,024 | $96.15 | $128K |
| 92250 Angiography | Office | 1,150 | 1,088 | $30.41 | $35K |
| 92083 Vision, Hearing, and Speech Services | Office | 1,084 | 1,056 | $55.72 | $60K |
| 92286 Standard X-ray | Office | 941 | 936 | $32.48 | $31K |
| 92132 Computerized Ophthalmic Imaging | Office | 772 | 619 | $25.75 | $20K |
| 92273 Test - Miscellaneous | Office | 636 | 615 | $116.55 | $74K |
| 92202 Ophthalmological E&M | Office | 488 | 475 | $13.59 | $6,633 |
| 92285 Standard X-ray | Office | 487 | 479 | $19.01 | $9,258 |
| 92004 Ophthalmological E&M | Office | 358 | 358 | $116.17 | $42K |
| 92133 Computerized Ophthalmic Imaging | Office | 290 | 285 | $30.47 | $8,837 |
| 76512 Ultrasound - Nonspecific | Office | 289 | 220 | $40.78 | $12K |
| 92134 Computerized Ophthalmic Imaging | Office | 193 | 188 | $34.18 | $6,597 |
| 76514 Ultrasound - Nonspecific | Office | 187 | 187 | $9.77 | $1,826 |
| 92012 Ophthalmological E&M | Office | 107 | 89 | $77.95 | $8,341 |
By year: 2022 $229K for 5,582 services; 2023 $192K for 4,689 services; 2024 $518K for 11,623 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 3,273 | 1,282 | $22.03 | $72K |
Medicare prescription drug claims, 2024
In 2024, the drug Steven Givner prescribed most often to Medicare patients was Latanoprost, with 551 prescriptions and refills. In total Steven Givner wrote 2,532 Medicare prescriptions that cost $564K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 551 | 634 | 110 | $3,222 |
| Restasis Cyclosporine | 322 | 328 | 68 | $201K |
| Loteprednol Etabonate Generic | 172 | 187 | 63 | $25K |
| Cyclosporine Generic | 143 | 145 | 33 | $36K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 133 | 133 | 74 | $1,174 |
| Brimonidine Tartrate Generic | 87 | 123 | 21 | $8,776 |
| Azelastine Hcl Generic | 86 | 92 | 23 | $1,552 |
| Xiidra Lifitegrast | 82 | 82 | 17 | $54K |
| Alrex Loteprednol Etabonate | 72 | 79 | 30 | $23K |
| Simbrinza Brinzolamide/Brimonidine Tart | 72 | 75 | 17 | $14K |
| Timolol Maleate Generic | 71 | 100 | 23 | $728 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 67 | 67 | 16 | $22K |
| Lumigan Bimatoprost | 60 | 84 | 24 | $24K |
| Eysuvis Loteprednol Etabonate | 45 | 52 | 17 | $21K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 44 | 76 | 13 | $714 |
Brand drugs: 1,467 claims; generic drugs: 1,065 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Givner $60.13 ($60.13 in general payments such as food, travel and fees) from 3 companies. The largest payer was Oyster Point Pharma, Inc. with $22.58.
| Company | Payments | Amount |
|---|---|---|
| Oyster Point Pharma, Inc. | 1 | $22.58 |
| Alcon Vision LLC ALC | 1 | $21.17 |
| Dompe US, Inc. | 1 | $16.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.